Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Porosome Therapeutics, Inc. See All Filings	D/A	2026-03-24 15:55:08 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001934919 Filed Document 0001376474-26-000247 Exclusions or Exemptions 506b Accepted Date 2026-03-24 15:55:08 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity
Porosome Therapeutics, Inc. See All Filings	D/A	2025-06-03 12:19:19 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001934919 Filed Document 0001376474-25-000506 Exclusions or Exemptions 506b Accepted Date 2025-06-03 12:19:19 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity
Porosome Therapeutics, Inc. See All Filings	D/A	2024-07-25 17:06:29 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001934919 Filed Document 0001376474-24-000338 Exclusions or Exemptions 506b Accepted Date 2024-07-25 17:06:29 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity
Porosome Therapeutics, Inc. See All Filings	D	2023-09-14 13:09:48 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001934919 Filed Document 0001376474-23-000433 Exclusions or Exemptions 506b Accepted Date 2023-09-14 13:09:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity
Viron Therapeutics Holdings, Inc. See All Filings	D	2022-06-24 11:04:12 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001934919 Filed Document 0001376474-22-000299 Exclusions or Exemptions 506b Accepted Date 2022-06-24 11:04:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets $No Revenues Type of Security Equity